A recent study suggests that individuals who stop using new slimming jabs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt traditional diet and exercise programs.
Research printed in a major health publication shows that while obese people can lose a large proportion of their total mass while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying such medications must be informed of the risk of fast weight regain when the therapy concludes," stated lead investigator Dr. Susan Jebb.
That rate of regain implies a reversion to starting weight within about a year and a half.
Analyzing Treatments
The analysis, which examined dozens of studies involving over 9,000 of patients, contrasted the results of the injectable medications with other pills.
Scientists point out that individuals who shed pounds through diet and exercise generally have a more gradual weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Doctors propose the mechanism of the drugs accounts for the heightened rebound.
These medications imitate a body's own chemical called GLP-1, which moderates appetite.
"Artificially providing the hormone levels far above than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication results in hunger is uncontrolled, making excessive eating a significant risk."
A Lifelong Disease?
Medical guidelines recommend the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Professionals argue that, given the likelihood of weight regain, the treatment is often ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the findings "underscore the long-term character of obesity," similar to managing conditions like diabetes.
User Testimonies
Users who have stopped the medication explain a powerful resurgence of hunger.
"I experienced a switch flipping and you're instantly starving," described one woman.
This challenge is compounded if users have not adopted sustainable dietary or behavioural changes during therapy.
Growing Adoption
Survey data indicate that millions of people in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is higher among females than males.
- The middle-aged age group shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, experts caution that while the jabs are powerful tools for weight loss, they are not a magic fix and lasting health benefits hinges on ongoing lifestyle management.
